TWN
TAIWAN FUND INC$92.02 +0.71 (+0.78%)
Oct 26 4:00 PM ET · prev $91.31
1 year
+60.8%
from $57.22 · Oct 27
30 days
−9.9%
from $102.10
52-week range
$52.64–106.89
−14% from high · low Dec 30
Avg volume 20D
20.5K
Oct 22 spike 54.9K
Short interest
🔒 Subscribers only
Insider net
+$3.3M
1 buyer · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read BULLISH 1 report · latest
Balance 0 bearish · 1 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- B Feb 26 1 insider buy $3.3M at $64.90
- S May 19 1 insider sell $11.9K at $88.82
- R Jul 15 The Taiwan Fund reported a massive NAV increase of $37.57 per share…
- X Jul 31 Short interest jumps 92.3% to 4.3K
- X Aug 14 Short interest jumps 45.5% to 6.2K
- X Aug 31 Short interest falls 66.5% to 2.1K
- X Sep 30 Short interest jumps 237.2% to 5.9K
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $3.3M at an average $64.90. 1 insider sold $11.9K. Price is 42% above their cost.
- InstitutionsMIXED
Q2 2026: 2 added (0 new), 0 trimmed or exited.
- TrendDOWNTREND
8% below its 50-day average.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| MORGAN STANLEY | ADD | $3.1M |
| UBS Group AG | ADD | $39.3K |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | TRIM | $7.1M |
| MORGAN STANLEY | DOUBLED | $1.3M |
| UBS Group AG | NEAR_EXIT | $21.0K |
| UBS Group AG | DOUBLED | $181.6K |
| BANK OF AMERICA CORP /DE/ | TRIM | $8.9K |
| UBS Group AG | TRIM | $52.0K |
Quarterly 13F filings are due 45 days after each quarter ends.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Jul 15, 2026
Earnings
The Taiwan Fund, Inc. Announces 3rd Quarter Earnings
BOSTON, July 15, 2026 /PRNewswire/ -- The Taiwan Fund, Inc. (the "Fund") (NYSE: TWN) announced today details regarding its investment performance…
Jul 6, 2026
Clinical Trial
Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)
Phase 2 · COMPLETED
Insider ledger
Form 4$3.3M
bought · 1 insider
$11.9K
sold · 1 insider
+41.8%
vs their $64.90 cost
| Date | Insider | Type | Value |
|---|---|---|---|
| May 19, 2026 | Rigger Shelley E Director | SELL | $11.9K |
| Feb 26, 2026 | Kirby William C. Director | BUY | $3.3M |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jul 15, 2026 SEC
The Taiwan Fund reported a massive NAV increase of $37.57 per share (47.36% total return) for the quarter ended May…
PRESS-RELEASE — Impact 7/10
Jul 15, 2026 Earnings
The Taiwan Fund, Inc. Announces 3rd Quarter Earnings
BOSTON, July 15, 2026 /PRNewswire/ -- The Taiwan Fund, Inc. (the "Fund") (NYSE: TWN) announced today
Jun 30, 2026 Inst.
MORGAN STANLEY — ADD
32,403 shares ($3.1M)
Jun 30, 2026 Inst.
UBS Group AG — ADD
409 shares ($39.3K)
May 19, 2026 Insider
Rigger Shelley E sold 134 shares
Director @ $88.82 ($11.9K)
Feb 26, 2026 Insider
Kirby William C. bought 50,686.9 shares
Director @ $64.90 ($3.3M)
SecBot reports
1 filing · 1 bullish · 0 bearishAll TWN filing & press-release reports (1)
- PRESS-RELEASE reportJul 15, 2026